Table 3.

Ezetimibe Versus Placebo: Longitudinal Changes in Liver Stiffness Values Using 2D MRE and 3D MRE

	Ezetimibe (n = 19)			Placebo (n = 21)			Difference
2D MRE	Baseline	Posttreatment	P Value	Baseline	Posttreatment	P Value	(P Value)
60 Hz	3.3 (1.1)	3.4 (1.3)	0.7374	3.2 (1.1)	3.3 (1.3)	0.6769	0.0 (0.9560)

	Ezetimibe (n = 16)			Placebo (n = 20 [40 Hz], n = 19 [60 Hz])			Difference
3D MRE	Baseline	Posttreatment	P Value	Baseline	Posttreatment	P Value	(P Value)
40 Hz	2.1 (0.9)	2.0 (0.6)	0.7556	2.2 (1.0)	2.1 (1.0)	0.2448	0.1 (0.6233)
60 Hz	2.7 (1.3)	2.5 (1.0)	0.1344	2.8 (1.2)	2.7 (1.2)	0.4207	−0.1 (0.4895)

Data are expressed as means (SD). Associated P values are from t test.